Abdolmohamad Rostami, MD, PhD

Abdolmohamad Rostami, MD, PhD

Contact Dr. Rostami

901 Walnut Street
Suite 403
Philadelphia, PA 19107

(215) 955-8100
(215) 503-1815 fax

Most Recent Peer-reviewed Publications

  1. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127
  2. 1,25-Dihydroxyvitamin D3 suppressed experimental autoimmune encephalomyelitis through both immunomodulation and oligodendrocyte maturation
  3. Selective depletion of CD11c+CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE
  4. Galectin-1 is essential for the induction of MOG35–55-based intravenous tolerance in experimental autoimmune encephalomyelitis
  5. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis
  6. Apoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4+ effector memory T cells
  7. IL-9 signaling affects central nervous system resident cells during inflammatory stimuli
  8. Emerging immunopharmacological targets in multiple sclerosis
  9. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation
  10. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- And tissue-specific microRNAs
  11. c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis
  12. Mechanisms of immunological tolerance in central nervous system inflammatory demyelination
  13. Granulocyte-macrophage colony-stimulating factor in central nervous system autoimmunity
  14. Expression of GM-CSF in T cells is increased in multiple sclerosis and suppressed by IFN-β therapy
  15. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity
  16. Astrocyte-derived lactosylceramide implicated in multiple sclerosis
  17. Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis
  18. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
  19. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells
  20. Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells